trending Market Intelligence /marketintelligence/en/news-insights/trending/yxRy75LAEmDNbdZhnO5rGQ2 content esgSubNav
In This List

Suda Pharmaceuticals to raise A$3.4M in rights offering

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Suda Pharmaceuticals to raise A$3.4M in rights offering

Suda Pharmaceuticals Ltd. is looking to raise up to A$3.4 million in a rights offering.

The Osborne Park, Western Australia-based drug delivery company is offering renounceable rights issue on a one for three basis, priced at 0.4 Australian cents per fully paid ordinary share.

Each two new shares subscribed under the transaction will come with one listed option exercisable for 1.5 Australian cents apiece until June 30, 2021.

Suda Pharmaceuticals will use the proceeds to strengthen its balance sheet, fund project development and address general working capital requirements.

The acceptance of offers will close June 21.